26 June 2020>: Clinical Research
Hepatitis B Surface Antigen (HBsAg) Kinetics in Chronic Hepatitis B Patients during Peginterferon Treatment
Kaifa Wang 1AEG , Guangyu Huang 2BCF* , Yagang Chen 2DF , Yuming Wang 34BFDOI: 10.12659/MSM.921487
Med Sci Monit 2020; 26:e921487
Table 6 Stratified analysis for HBsAg kinetics of the uncured patients.
Pattern | Baseline HBeAg (IU/mL, median (Q1, Q3)) | Baseline ALT (U/L, median (Q1, Q3)) | Baseline neutrophils (109/L, median (Q1, Q3)) |
---|---|---|---|
Pattern 1 | 0.45 (0.38, 27.28)(n=33) | 25.00 (18.25, 55.75)(n=42) | 3.65 (2.50, 4.30)(n=46) |
Pattern 2 | 0.53 (0.51, 18.09)(n=3) | 31.00 (13.25, 255.75)(n=4) | 3.00 (2.65, 3.65)(n=4) |
Pattern 3 | 1.23 (0.41, 870.21)(n=33) | 42.00 (20.00, 124.25)(n=36) | 3.15 (2.80, 4.10)(n=36) |
Pattern 4 | 0.51 (0.31, 11.81)(n=12) | 37.50 (23.25, 137.25)(n=14) | 3.20 (3.00, 3.70)(n=)15 |
Pattern 5 | 124.64 (0.34, 1012.55)(n=6) | 89.90 (45.50, 226.50)(n=5) | 3.10 (2.90, 3.80)(n=7) |
χ | 4.932 | 5.936 | 1.922 |
P | 0.294 | 0.204 | 0.750 |
n is sample number. |